Cargando…

Hepatotoxicity Secondary to Levofloxacin Use

Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Panahi, Ladan, Surani, Salim Surani, Udeani, George, Patel, Niraj P, Sellers, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317250/
https://www.ncbi.nlm.nih.gov/pubmed/34336465
http://dx.doi.org/10.7759/cureus.15973
_version_ 1783730035049365504
author Panahi, Ladan
Surani, Salim Surani
Udeani, George
Patel, Niraj P
Sellers, Jacob
author_facet Panahi, Ladan
Surani, Salim Surani
Udeani, George
Patel, Niraj P
Sellers, Jacob
author_sort Panahi, Ladan
collection PubMed
description Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepatotoxicity cases are reported. Current recommendations advise clinicians to discontinue levofloxacin immediately if the patient develops signs and symptoms of hepatitis. This case report presents a 79-year-old male who was prescribed levofloxacin 500 mg by mouth daily for seven days. The patient had a past medical history of dementia, seizures, cerebral vascular accident, pulmonary fibrosis, and chronic kidney disease. Upon admission, the patient began to show signs and symptoms of liver injury. We hereby present a case report and a review of significant literature on levofloxacin-induced liver injury.
format Online
Article
Text
id pubmed-8317250
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83172502021-07-31 Hepatotoxicity Secondary to Levofloxacin Use Panahi, Ladan Surani, Salim Surani Udeani, George Patel, Niraj P Sellers, Jacob Cureus Internal Medicine Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepatotoxicity cases are reported. Current recommendations advise clinicians to discontinue levofloxacin immediately if the patient develops signs and symptoms of hepatitis. This case report presents a 79-year-old male who was prescribed levofloxacin 500 mg by mouth daily for seven days. The patient had a past medical history of dementia, seizures, cerebral vascular accident, pulmonary fibrosis, and chronic kidney disease. Upon admission, the patient began to show signs and symptoms of liver injury. We hereby present a case report and a review of significant literature on levofloxacin-induced liver injury. Cureus 2021-06-27 /pmc/articles/PMC8317250/ /pubmed/34336465 http://dx.doi.org/10.7759/cureus.15973 Text en Copyright © 2021, Panahi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Panahi, Ladan
Surani, Salim Surani
Udeani, George
Patel, Niraj P
Sellers, Jacob
Hepatotoxicity Secondary to Levofloxacin Use
title Hepatotoxicity Secondary to Levofloxacin Use
title_full Hepatotoxicity Secondary to Levofloxacin Use
title_fullStr Hepatotoxicity Secondary to Levofloxacin Use
title_full_unstemmed Hepatotoxicity Secondary to Levofloxacin Use
title_short Hepatotoxicity Secondary to Levofloxacin Use
title_sort hepatotoxicity secondary to levofloxacin use
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317250/
https://www.ncbi.nlm.nih.gov/pubmed/34336465
http://dx.doi.org/10.7759/cureus.15973
work_keys_str_mv AT panahiladan hepatotoxicitysecondarytolevofloxacinuse
AT suranisalimsurani hepatotoxicitysecondarytolevofloxacinuse
AT udeanigeorge hepatotoxicitysecondarytolevofloxacinuse
AT patelnirajp hepatotoxicitysecondarytolevofloxacinuse
AT sellersjacob hepatotoxicitysecondarytolevofloxacinuse